ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 065,26
-1,53%
DAX
18 691,32
0,05%
Brent Oil
81,31
-0,27%
Bitcoin
67 889,56
-1,76%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biodelivery Sciences International (MM) (BDSIW)

  7. Biodelivery Sciences International (MM) (BDSIW) Actualités

BDSIW

Biodelivery Sciences International (MM) (BDSIW)

Biodelivery Sciences International (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BDSIW
DateHeureSourceTitreSymboleSociété
08/11/200515h44Business WireBDSI Announces Supply Agreement Relating to BEMA(TM) Fentanyl; Agreement with Aveva Drug Delivery Systems a Key Milestone as BDSNASDAQ:BDSIWBiodelivery Sciences International (MM)
01/11/200513h30Business WireBDSI Prepares For Phase III with BEMA(TM) Fentanyl Following Positive Results of Comparative Pharmacokinetic StudyNASDAQ:BDSIWBiodelivery Sciences International (MM)
05/10/200517h13Business WireBDSI Closes Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
30/09/200514h04Business WireBDSI Prices Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
16/09/200522h30Business WireBDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq IndependenceNASDAQ:BDSIWBiodelivery Sciences International (MM)
20/07/200516h28Business WireBDSI Announces Acceptance of Emezine(R) NDA for Review By FDANASDAQ:BDSIWBiodelivery Sciences International (MM)
18/07/200517h03Business WireBDSI Secures $7 Million Financing Commitment For Development of BEMA(TM) Fentanyl; Funding Targeted for Phase III Trials of CancNASDAQ:BDSIWBiodelivery Sciences International (MM)
03/06/200513h00Business WireBDSI Secures Additional $2.5 Million Financing With Laurus Master FundNASDAQ:BDSIWBiodelivery Sciences International (MM)
02/05/200513h30Business WireBDSI Announces Submission of NDA for Emezine; First Transmucosal Product for the Treatment of Nausea and VomitingNASDAQ:BDSIWBiodelivery Sciences International (MM)
12/11/200422h37PR Newswire (US)BDSI Reports Financial Results for the Third Quarter Ended September 30, 2004NASDAQ:BDSIWBiodelivery Sciences International (MM)
13/04/200418h00PR Newswire (US)BioDelivery Sciences International, Inc. Announces Licensing of Its Topical BioNasal (TM) Amphotericin B for Chronic SinusitisNASDAQ:BDSIW
06/04/200414h00PR Newswire (US)BioDelivery Sciences International, Inc. Reports 2003 ResultsNASDAQ:BDSIWBiodelivery Sciences International (MM)
 Showing the most relevant articles for your search:NASDAQ:BDSIW

Dernières Valeurs Consultées

EU
ORA
Orange
EU
VIV
Vivendi
USI
USTECH100
US Tech 100
EU
AI
Air Liquide
EU
PX4
SBF 120
EU
ML
Michelin
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
NVDA
NVIDIA
EU
AF
Air FranceKLM
NYSE
DIS
Walt Disney
EU
HO
Thales
NYSE
KO
Coca Cola
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés